Enrollment Begins in TriVascular's LUCY Study
August 24, 2015—TriVascular, Inc. announced that the first patient was enrolled and treated in the LUCY study, which seeks to study endovascular aneurysm repair (EVAR) in women, who are underrepresented candidates for abdominal aortic aneurysm (AAA) repair. According to TriVascular, the LUCY study is a prospective, consecutively enrolling, nonrandomized multicenter postmarket registry designed to evaluate the company’s ultra-low-profile (14-F) Ovation abdominal stent graft platform when used in the endovascular treatment of AAA in women compared to men. The primary objective of the LUCY study is to demonstrate the clinical outcomes and benefits associated with using the Ovation abdominal stent graft platform in both women and men, including low rates of access-related vascular complications, low mortality rates, and high eligibility rates, even in patients who tend to have small access vessel diameters and challenging aortic neck anatomy.
